Online inquiry

IVTScrip™ mRNA-Human AK307192, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK18349MR)

This product GTTS-WK18349MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the AK307192 protein. This product can be used in CD1C-CD141- dendritic cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 100506115
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AK307192, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK18349MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK18342MR IVTScrip™ mRNA-Human AK093551, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AK093551
GTTS-WK16843MR IVTScrip™ mRNA-Human AK095700, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AK095700
GTTS-WK15045MR IVTScrip™ mRNA-Human AK124399, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AK124399
GTTS-WK20149MR IVTScrip™ mRNA-Human AK307192, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AK307192
GTTS-WK18943MR IVTScrip™ mRNA-Human AK095700, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA AK095700
GTTS-WK26703MR IVTScrip™ mRNA-Human APCDD1L-AS1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA APCDD1L-AS1
GTTS-WK26515MR IVTScrip™ mRNA-Human ARHGEF26-AS1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGEF26-AS1
GTTS-WK18945MR IVTScrip™ mRNA-Human AK124399, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA AK124399
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →